Evidence map›Paper›PMID 30062390›Full record

ReviewMycopathologia2019

Cutaneous Mucormycosis by Saksenaea vasiformis: An Unusual Case Report and Review of Literature.

Ioannis D Gkegkes, Ioannis Kotrogiannis, Filitsa Konstantara, Athina Karetsou, Sofia Tsiplakou, Eleftherios Fotiou, Sotiria Stamopoulou, Christos Papazacharias, Ioannis A Paraskevopoulos

Abstract readCase ReportsReview
PubMed Publisher
In one paragraph

Review in Mycopathologia, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. The molecular basis of intrinsic resistance to azoles inAntimicrobial agents and chemotherapy · 2026
    Article
  2. Article
  3. Article
  4. Cutaneous Invasive Fungal Infections withPlastic and reconstructive surgery. Global open · 2022
    Article
  5. Article
  6. Article
  7. Combat trauma-related invasive fungal wound infections.Current fungal infection reports · 2020
    Article
  8. Unusual case of otomycosis caused byMedical mycology case reports · 2020
    Article
  9. International journal of microbiology · 2019
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Ioannis D GkegkesFirst Department of General Surgery, General Hospital of Attica "KAT", 141 Oropou Str., 14232, Athens, Greece. ioannisgkegkes@gmail.com.
Ioannis KotrogiannisFirst Department of General Surgery, General Hospital of Attica "KAT", 141 Oropou Str., 14232, Athens, Greece.
Filitsa KonstantaraFirst Department of General Surgery, General Hospital of Attica "KAT", 141 Oropou Str., 14232, Athens, Greece.
Athina KaretsouFirst Department of General Surgery, General Hospital of Attica "KAT", 141 Oropou Str., 14232, Athens, Greece.
Sofia TsiplakouMicrobiology Department, General Hospital of Attica "KAT", Athens, Greece.
Eleftherios FotiouFirst Department of General Surgery, General Hospital of Attica "KAT", 141 Oropou Str., 14232, Athens, Greece.
Sotiria StamopoulouFirst Department of General Surgery, General Hospital of Attica "KAT", 141 Oropou Str., 14232, Athens, Greece.
Christos PapazachariasFirst Department of General Surgery, General Hospital of Attica "KAT", 141 Oropou Str., 14232, Athens, Greece.
Ioannis A ParaskevopoulosFirst Department of General Surgery, General Hospital of Attica "KAT", 141 Oropou Str., 14232, Athens, Greece.
General Hospital of Attica · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSaksenaea vasiformis is one of the numerous fungi of the Order Mucorales. Rapid progression and invasion of neighboring tissues are the most characteristic features of S. vasiformis mucormycosis.

aimThe objective of this review is the management of this type of infections.

methodsCase report and literature review.

resultsA 62-year old woman, without a history of immunocompromisation, developed a localized cutaneous infection at her right thigh. No trauma, skin laceration or insect bite was reported at the side of infection. The initial treatment was surgical debridements and intravenous administration of amphotericin B/posaconazole. In order to avoid the further rapid progression of the infection and save her life, it was decided to proceed to amputation of the patient's right leg. This is the first case of S. vasiformis cutaneous infection in an immunocompetent patient, in Greece.

conclusionEarly diagnosis of S. vasiformis mucormycosis is of paramount importance. Clinical suspicion, based on the rapid progression of the infection and on the medical history of the patient, is sufficient to start antifungal treatment. Broad, aggressive, and repeated surgical debridement of the infection site together with systemic antifungal agents administration is the key point for successful treatment.

Indexed as

Administration, IntravenousAmphotericin BAmputation, SurgicalAntifungal AgentsDebridementDermatomycosesFemaleGreeceHumansMiddle AgedMucoralesMucormycosisThighTriazolesAmphotericin BAntifungal AgentsposaconazoleTriazolesAmphotericin BCutaneous zygomycosisMucormycosisPosaconazoleSaksenaea vasiformisZygomycosis

Identifiers

PMID30062390
OpenAlexW2887096455

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.